Refractory Focal Epilepsy

NO LONGER ACCEPTING APPLICATIONS

Published on:

September 18, 2024

Sign-up Expiration:

Updated:

Topics:

Locations:

Charlotte, NC

Dr. Robert Nahouraii

A Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of BHV-7000 in Subjects with Refractory Focal Epilepsy.

View Additional Information

View Clinical Trial Attachment

ENDED

Other Enrolling Clinical Trials

View All Enrolling Trials

Adults with Moderate-to-Severe Plaque Psoriasis and Obesity

This study to see if weight loss improves plaque psoriasis

View Trial

Severe Alopecia Areata

This study is to evaluate efficacy and safety of Upadacitinib (Rinvoq) in adult and adolescent subjects with severe Alopecia Areata (AA)

View Trial

Chronic Kidney Disease

A study to evaluate quarterly and monthly TOUR006 in participants with Chronic Kidney Disease and Elevated High-Sensitivity C-Reactive Protein.

View Trial

Asthma Clinical Trial - TEVA

A study to evaluate the efficacy and safety of Fluticasone Propionate/Albuterol Sulfate fixed-dose combination on Severe Asthma Exacerbations in patients.

View Trial

Migraine Study for Adolescents 12-17 years

A study to evaluate the efficacy and safety of IV Eptinezumab in adolescents (12-17 years) for the preventive treatment of chronic migraines.

View Trial

Heart Failure with Reduced Ejection Fraction

Study to evaluate the efficacy, safety and tolerability of JTT‑861 administered in subjects with Heart Failure with Reduced Ejection Fraction.

View Trial

Sign-Up, Make an Appointment, or Receive More Information

Thank you for your interest in our clinical research trials. Please enter your contact information below and someone will reach out to you shortly to see if you qualify. You can also call us at 1-800-785-3150 or email participate@onsiteclinical.com

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.